Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1186 AL 1200

Tau, tau kinases, and tauopathies: An updated overview

Montalto G, Ricciarelli R.

Biofactors. 2023 May-Jun;49(3):502-511. doi: 10.1002/biof.1930. Epub 2023 Jan 23.

Challenges and Opportunities of Metal Chelation Therapy in Trace Metals Overload-Induced Alzheimer's Disease

Chaudhari V, Bagwe-Parab S, Buttar HS, Gupta S, Vora A, Kaur G.

Neurotox Res. 2023 Jun;41(3):270-287. doi: 10.1007/s12640-023-00634-7. Epub 2023 Jan 27.

Research progress of PPARγ regulation of cholesterol and inflammation in Alzheimer's disease

Gu L, Ju Y, Hu M, Zheng M, Li Q, Zhang X.

Metab Brain Dis. 2023 Mar;38(3):839-854. doi: 10.1007/s11011-022-01139-6. Epub 2023 Feb 1.

Selenium-enriched foods and their ingredients: As intervention for the vicious cycle between autophagy and overloaded stress responses in Alzheimer's disease

Chen M, Wu Q, Zhu Z, Huang A, Zhang J, Bekhit AEA, Wang J, Ding Y.

Crit Rev Food Sci Nutr. 2024;64(19):6672-6685. doi: 10.1080/10408398.2023.2172547. Epub 2023 Feb 2.

Clinical efficacy and safety of compound Congrong Yizhi Capsules on Alzheimer's disease in mainland China: A systematic review with trial sequential analysis and GRADE assessment

Wang Y, Wang N, Xu Z, Liu S, Liang X, Zhang Y, Jin X.

J Ethnopharmacol. 2023 Jun 12;309:116208. doi: 10.1016/j.jep.2023.116208. Epub 2023 Jan 31.

An insight into the TAM system in Alzheimer's disease

Zhou S, Li Y, Zhang Z, Yuan Y.

Int Immunopharmacol. 2023 Mar;116:109791. doi: 10.1016/j.intimp.2023.109791. Epub 2023 Feb 2.

Acridine: A Scaffold for the Development of Drugs for Alzheimer's Disease

Sharma A, Piplani P.

Curr Top Med Chem. 2023;23(13):1260-1276. doi: 10.2174/1568026623666230203141543.

Treatment of Alzheimer's Disease: Contemporary Perspectives in Medicinal Chemistry

de Oliveira AS.

Curr Med Chem. 2023;30(6):667-668. doi: 10.2174/092986733006221208094952.

Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease

Vitek GE, Decourt B, Sabbagh MN.

Expert Opin Investig Drugs. 2023 Feb;32(2):89-94. doi: 10.1080/13543784.2023.2178414. Epub 2023 Feb 28.

Myeloid Cells As a Promising Target for Brain-Bone Degenerative Diseases from a Metabolic Point of View

Pang Y, Zhu S, Xu J, Su C, Wu B, Zhang C, Gao J.

Adv Biol (Weinh). 2023 Oct;7(10):e2200321. doi: 10.1002/adbi.202200321. Epub 2023 Feb 7.

Local and Systemic Hypoxia as Inductors of Increased Aluminum and Iron Brain Accumulation Promoting the Onset of Alzheimer's Disease

Cirovic A, Cirovic A, Orisakwe OE, Lima RR.

Biol Trace Elem Res. 2023 Nov;201(11):5134-5142. doi: 10.1007/s12011-023-03599-y. Epub 2023 Feb 9.

The Breakthroughs and Caveats of Using Human Pluripotent Stem Cells in Modeling Alzheimer's Disease

Sahlgren Bendtsen KM, Hall VJ.

Cells. 2023 Jan 27;12(3):420. doi: 10.3390/cells12030420.

The Pursuit of the "Inside" of the Amyloid Hypothesis-Is C99 a Promising Therapeutic Target for Alzheimer's Disease?

Takasugi N, Komai M, Kaneshiro N, Ikeda A, Kamikubo Y, Uehara T.

Cells. 2023 Jan 31;12(3):454. doi: 10.3390/cells12030454.

Natural Inhibitors of Cholinesterases: Chemistry, Structure-Activity and Methods of Their Analysis

Smyrska-Wieleba N, Mroczek T.

Int J Mol Sci. 2023 Feb 1;24(3):2722. doi: 10.3390/ijms24032722.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias